miR‐375 Inhibits the Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Suppressing PDK1

Purpose . In patients with nasopharyngeal carcinoma (NPC), the expression of PDK1 is remarkably improved in NPC tissue and correlated with the clinicopathological severity of NPC. We expressed miR‐375 in NPC cells to study the effects on PDK1 gene expression. We also investigated the mechanism by which miR‐375 affects the biological behavior of NPC cells through effects on PDK1. Methods . qRT‐PCR was carried out to analyze miR‐375 and PDK1 levels in NPC cells. NPC cells were transfected with miR‐375 inhibitor or miR‐375 mimic. CCK‐8 testing, colony formation testing, transwell testing, and flow cytometry analysis were carried out to quantify the cells’ biological behavior. Rescue experiments demonstrated that the recovery of PDK1 expression was able to reverse the influence of miR‐375 inhibition on NPC diffusion and intrusion. The interaction between miR‐375 and PDK1 was verified by dual‐luciferase reporter gene testing. Results . The results revealed that miR‐375 has a negative regulatory effect on PDK1 expression in NPC cells. Furthermore, PDK1 is a target gene for miR‐375. The empirical results obtained demonstrated a negative correlation between tumor development and the level of miR‐375 expression in NPC tissues. The excessive expression of miR‐375 and the downregulation of PDK1 facilitated the diffusion and invasion of NPC cells. Conclusion . The diffusion and incursion of NPC cells may be inhibited by direct targeting of PDK1 and decreasing the expression of miR‐375. Our study highlights efforts to target PDK1 and miR‐375 as potential therapeutic strategies for use in the treatment of NPC.